University of Alabama Utilizes Mawi’s iSWAB-Protein for…
READ MORE
FUJIFILM Wako Pure Chemical will be an authorized agent and distributor for Mawi products in Japan to detect viruses such as COVID-19. HAYWARD, CA – October 04, 2021 - Mawi DNA Technologies has signed a distribution agreement with FUJIFILM Wako Pure Chemical Corporation, a leader in…
READ MORE
Supplies To Rural Africa And Morocco
Supplying Mawi Technology to Rural Africa and Morocco Mawi DNA is working with Biotessia to start a local production site for DNA sample collection technologies and kits. These will be provided to African markets at a significantly lower cost. Mawi DNA Technologies (Mawi), a leading…
READ MORE
Mawi DNA Awarded Leading Innovators of Biosample Collection Technology 2022
The Global Health & Pharma (GH&P) Magazine awarded Mawi DNA Technologies with the 2022 Leading Innovators of Biosample Collection Technology Award. Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is…
READ MORE
Mawi DNA’s Joint Venture: State-of-the-Art Manufacturing Facility in Morocco for African Market
Announcing Mawi DNA's joint venture with BIOTESSIA to establish a state-of-the-art manufacturing facility in Morocco to serve the African market. This will be accomplished via the unique and innovative biosampling technology set forth by Mawi DNA. BIOTESSIA's strategy and vision are centered around ensuring health needs…
READ MOREiSWAB Microbiome Collection Media: Supporting Home Collection of COVID-19 Samples
The University of California, San Diego (UCSD) EXCITE lab has been extensively using Mawi’s iSWAB-Microbiome technology for campus and community surveillance. Mawi DNA Technologies is honored to announce the FDA has granted Emergency Use Authorization (EUA) for UCSD Excite Lab’s COVID test, submitted with iSWAB-Microbiome…
READ MOREHelix Achieves A Key Milestone in the Fight Against COVID-19!
Worldwide COVID-19 testing continues to ramp up consistently, predominantly using RT-PCR as the “gold standard". However, more sensitive testing applications are now being introduced. We are proud to announce that Helix has received emergency use authorization (EUA) from the FDA for COVID-19 testing using next…
READ MORECosmosID Reveals What’s Really Inside Your Mouth
Utilizing oral samples collected with iSWAB-Microbiome, the universal collection technology from Mawi DNA Technologies! Our ongoing partnership with CosmosID is already bringing more insight to the microbiome research community through our combined ability to provide a true end to end solution for microbiome analysis! Read…
READ MOREMawi and CosmosID Collaborate to Enable More Precise Microbiome Analysis
HAYWARD, CA – January 13, 2020 - Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces a collaboration with CosmosID to help advance understanding of microbiome complexity in different biological samples and environments. “Our fellow microbiome researchers have…
READ MOREiSWAB-Cells Now Available!
Mawi DNA Technologies is pleased to announce the release of the new iSWAB-Cells Collection System and Cell Stabilization Buffer! Link to the Press Release: https://www.businesswire.com/news/home/20180924005306/en/Mawi-DNA-Technologies-Launches-iSWAB-Cell-Stabilization Product Page: iSWAB-Cells Collection System and… read more →
READ MOREiSWAB Patent granted for the EU!
The European Patent Office (EPO) issued a Decision to Grant Mawi DNA Technologies their patent for the EU with regards to iSWAB-Sample collection technology. The patent issued on August 29, 2018. For more information visit this link: https://patents.google.com/patent/EP2958498B1/en
READ MORE
